Insider Transaction Report for Egan Dwight H

Dwight H. Egan, Chief Executive Officer and Director of Co-Diagnostics, Inc. (CODX), reported a series of transactions on May 23, 2026. Egan acquired 4,584 shares of Common Stock at $0.00 per share, increasing his post-transaction holdings to 29,526 shares. Concurrently, he disposed of 1,633 shares of Common Stock at $5.07 per share, resulting in 27,893 shares remaining. Additionally, Egan was involved in a derivative transaction, disposing of 4,584 Restricted Stock Units (RSUs) with a market value of $0.00. These RSUs were part of awards granted under the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, with vesting schedules commencing in late 2023 and 2024. The disposal of RSUs is related to satisfying tax withholding obligations through a "sell to cover" transaction, as mandated by the issuer, and does not represent a discretionary trade. His post-transaction holdings for RSUs amount to 9,166 units, with 13,750 underlying Common Stock shares.